Search

everythinglearnresearchcommunity

for

Search:↓

The anti-viral drug Elvitegravir may protect brain cells from damage related to neurodegenerative diseases.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

The Drug Ontology was updated to better classify drugs for hypertension, malaria, and opioid abuse, and to allow for more accurate research queries.

Zinc deficiency in alcoholic cirrhosis patients causes skin issues, and zinc treatment improves symptoms.

Ocrelizumab may cause pancreatitis in some patients.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Indinavir therapy can cause reversible skin, hair, and nail darkening.

Switching from escitalopram to duloxetine improved hair loss.

Newer retinoid drugs are effective for skin conditions but have significant side effects.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.

Ixekizumab is effective and safe for patients who did not improve with etanercept treatment for psoriasis.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Low-dose oral minoxidil is an effective and safe treatment for hair loss.

A dissolving microneedle patch with dutasteride offers effective, long-lasting hair loss treatment with fewer side effects.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

Methylated flavonoids may effectively reduce depression and inflammation caused by finasteride.

Trametinib can effectively treat severe kaposiform lymphangiomatosis when other treatments fail.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

A patient developed nerve problems as a side effect of a hair loss treatment called tofacitinib.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Flutamide, a medication used for excessive hair growth, can cause severe liver damage in women.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Teriflunomide is safe and tolerable for treating relapsing-remitting multiple sclerosis, with manageable side effects.

Low-dose methotrexate is generally safe but can cause mild to severe side effects, and folic acid can reduce these risks.

Thalidomide significantly improved hair regrowth in a woman with lichen planopilaris.

Combination therapy helped patient with advanced Hidradenitis Suppurativa achieve remission.